Craft

RepliCel

Total Funding

$6.2 M

Revenue

$353 K

FY, 2025

RepliCel Summary

Company Summary

Overview
RepliCel (also known as 0913693 B.C.) is a regenerative medicine company focused on aesthetics and orthopedics. It develops cell therapy products to restore cellular function, rejuvenate aging or sun damaged skin, regrow hair, and repair tendons. In addition, the company develops a programmable cell injector device designed for dermal injections of cells, dermal filler products, and other products injected through the skin.
Type
Private
Status
Active
Founded
2010
HQ
Vancouver, CA | view all locations
Website
https://replicel.com/
Cybersecurity rating
Sectors

Key People

  • David Hall

    David Hall, Chairman

    • Peter Lewis

      Peter Lewis, Director

      • Andrew Schutte

        Andrew Schutte, Director

        • R. Lee Buckler

          R. Lee Buckler, President, CEO & Director

          LocationsView all

          1 location detected

          • Vancouver, BC HQ

            Canada

            570 Granville St #900

          RepliCel Financials

          Summary Financials

          Revenue (FY, 2025)
          $C353.0K
          Gross profit (FY, 2025)
          $C353.0K
          Net income (FY, 2025)
          ($C247.0K)
          Cash (FY, 2025)
          $C6.0K
          EBIT (FY, 2025)
          ($C205.0K)

          Footer menu